Vaccines for children

Ended Indefinite Delivery Contract Awarded Last action

Contract number
75D30122D13472
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$3,301,328,000.00
Maximum order
$3,301,328,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

This Indefinite Delivery, Indefinite Quantity contract was awarded to Merck Sharp & Dohme LLC by the Centers for Disease Control and Prevention (CDC) on April 1, 2022, with a ceiling value of $3.301 billion and a performance period extending through March 31, 2023. The contract supports the CDC's Vaccines for Children program, a federally funded initiative established under Section 317(j) of the Public Health Service Act to provide vaccinations to uninsured, underinsured, and Medicaid-eligible children. Merck was selected through an open, multiple-award competitive procurement with no set-aside designation to supply up to 23 standard pediatric vaccines meeting FDA-licensed manufacturing requirements and minimum 12-month shelf-life specifications. Vaccine quantities range from 100 doses to 13 million doses depending on the specific immunization product, with all deliveries designated FOB destination to the 50 states and U.S. territories for distribution through existing CDC immunization infrastructure.

The contract establishes flexible procurement mechanisms enabling the CDC to issue delivery orders for pediatric vaccines on an as-needed basis to support national immunization coverage and disease prevention objectives. All vaccines procured under this vehicle must maintain current FDA licensing and comply with pharmaceutical manufacturing quality standards. Performance is conducted within the United States, allowing the CDC to manage vaccine inventory requirements and distribution logistics across federal and state healthcare programs without requiring periodic re-competition or new contract awards. This indefinite delivery structure provides the CDC with pricing certainty and supply chain continuity while maintaining Merck's established role as a critical supplier of pediatric immunization products to federal healthcare programs.

Transactions

Action Obligated Date
Other Administrative Action P00011 $0
Supplemental Agreement for work within scope P00010 $0
Other Administrative Action P00009 $0
Supplemental Agreement for work within scope P00008 -$66,181,967
Supplemental Agreement for work within scope P00007 $0
Funding Only Action P00006 $240,268,737
Supplemental Agreement for work within scope P00005 $102,501,091
Funding Only Action P00004 $344,947,344
Funding Only Action P00003 $288,224,184
Funding Only Action P00002 $655,386,530
Supplemental Agreement for work within scope P00001 $0
Original award $602,055,084
Show all 12

Quick answers

Who was awarded contract 75D30122D13472?

75D30122D13472 was awarded to Merck Sharp & Dohme LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on April 1, 2022.

How much is contract 75D30122D13472 worth?

75D30122D13472's own ceiling is $3,301,328,000. A single order can be worth up to $3,301,328,000.

Who can order from contract 75D30122D13472?

75D30122D13472 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75D30122D13472 competed?

The extent of competition for 75D30122D13472 was full and open competition. The government received 5 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login